Health Condition 1: N529- Male erectile dysfunction, unspecified
Conditions
Interventions
Intervention1: Homoeopathic medicine: Participants who are assigned to the SM group and CH group will be given homoeopathic medicines selected based on Sehgalâ??s Methods and Classical Homeopathy resp
Sponsors
Amulya Ratna Sahoo
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male patients aged between 18 years to 70 years will be enrolled for in this study. 2. Cases of erectile dysfunction fulfilling the DSM-5 diagnostic criteria as below will be enrolled. a. Marked difficulty in obtaining an erection during sexual activity or marked difficulty in maintaining an erection until the completion of sexual activityor marked decrease in erectile rigidity in more than 75% of sexual activity. b. The symptoms above have continued for approximately 6 months. c. The symptoms are causing significant distress to the individual. d. The dysfunction is not linked to nonsexual mental disorder, a medical condition, the effects of a drug or medication, or severe relationship distress or other significant stressors.
Exclusion criteria
Exclusion criteria: 1. Patients who are unwilling to give informed consent. 2. Immuno-compromised and/or suffering from critical illnessand/or severely drug/alcohol addicted will be excluded fromthe study. 3. Patients under any kind of treatment for erectile dysfunction at least for last 1 month will be excluded from the study, or will not be considered for the study before completion of one month wash-out period after discontinuation of the medicine. 4. Patients with severe relationship distress or having significant stressors such as recent death of near and dear ones, divorce and loss of a job will be excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome measure will be the change in IIEF-5 scoreTimepoint: This will be assessed at baseline, 1st, 2nd & 3rd month of treatment or at the end of the study. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome measures will be the change in the WHO-QOL BREF score.Timepoint: This will be assessed at the baseline and 3rdmonth of treatment or at the end of the study. | — |
Countries
India
Contacts
Public ContactDr Charanjeet Singh
Sri Ganganagar Homoeopathic Medical College
Outcome results
None listed